LTR

  • Inhibitory Selectivity
  • Solubility
Catalog No. Product Name Solubility(25°C)
Water DMSO Alcohol
S1633 Zafirlukast <1 mg/mL 100 mg/mL <1 mg/mL
S4211 Montelukast Sodium 100 mg/mL 100 mg/mL 100 mg/mL
S8126 MK571 <1 mg/mL 100 mg/mL 19 mg/mL
S5783 Montelukast <1 mg/mL 100 mg/mL 10 mg/mL

LTR Products

New LTR Products
Catalog No. Information Product Use Citations Product Validations
S1633

Zafirlukast

Zafirlukast is an oral leukotriene receptor antagonist (LTRA), used to prevent asthma symptoms.

S4211

Montelukast Sodium

Montelukast selectively antagonizes leukotriene D 4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1.

S8126

MK571

MK-571 is a selective, orally active CysLT1 receptor(Cysteinyl leukotriene receptor) antagonist.

S5783New

Montelukast

Montelukast is a leukotriene receptor antagonist used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.

Catalog No. Information Product Use Citations Product Validations
S1633

Zafirlukast

Zafirlukast is an oral leukotriene receptor antagonist (LTRA), used to prevent asthma symptoms.

S4211

Montelukast Sodium

Montelukast selectively antagonizes leukotriene D 4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1.

S8126

MK571

MK-571 is a selective, orally active CysLT1 receptor(Cysteinyl leukotriene receptor) antagonist.

2017, 52:65-71

2018, 129:388-399

2017, 106:313-327

S5783New

Montelukast

Montelukast is a leukotriene receptor antagonist used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.